首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Immobilized P2X2 purinergic receptor stationary phase for chromatographic determination of pharmacological properties and drug screening.
【24h】

Immobilized P2X2 purinergic receptor stationary phase for chromatographic determination of pharmacological properties and drug screening.

机译:固定化的P2X2嘌呤能受体固定相用于色谱法测定药理性质和药物筛选。

获取原文
获取原文并翻译 | 示例
           

摘要

The purinergic receptor signaling system plays an important role in communication between cells in the nervous system and opens new opportunities for screening of potential drugs. Our objective was to explore the pharmacological properties and establish a new methodology for ligand screening for the P2X2 receptor, which has been developed by the combinatorial library approach Systematic Evolution of Ligands by Exponential enrichment (SELEX). To this end, membranes of 1321N1 cells stably transfected with rat P2X2 receptors were resuspended in 2% cholate detergent and subsequently coupled onto an immobilized artificial membrane (IAM). The IAM-cholate-P2X2 mixture was then dialyzed, centrifuged and packed into a FPLC column. Equilibrium binding to the receptor and competition between ATP and the purinergic antagonists suramin and 2'3'-O-(2,4,6-trinitrophenyl) adenosine 5'-triphosphate (TNP-ATP) were analyzed by a chromatographic assay using 32P alpha ATP as a radioligand. Our data indicate that suramin does not compete with ATP for the ligand binding site and TNP-ATP is a competitive antagonist, confirming previous studies [C.A. Trujillo, A.A. Nery, A.H. Martins, P. Majumder, F.A. Gonzalez, H. Ulrich, Biochemistry 45 (2006) 224-233]. In addition, we demonstrate that this assay can be used in in vitro selection procedures for RNA aptamers binding to P2X2 receptors. The results demonstrate that the receptor can be immobilized in a stable format and reused over an extended period of time, facilitating the exploration of ligand-receptor interactions and screening of combinatorial pools for possible ligands.
机译:嘌呤能受体信号系统在神经系统细胞之间的通讯中起重要作用,并为筛选潜在药物提供了新的机会。我们的目标是探索药理特性,并建立用于P2X2受体配体筛选的新方法,该方法已通过组合文库方法通过指数富集的配体系统进化(SELEX)开发。为此,将用大鼠P2X2受体稳定转染的1321N1细胞膜重悬于2%胆酸盐去污剂中,然后偶联至固定的人造膜(IAM)上。然后将IAM-胆酸盐-P2X2混合物透析,离心并填充到FPLC色谱柱中。通过使用32Pα的色谱分析法分析了与受体的平衡结合以及ATP与嘌呤能拮抗剂suramin和2'3'-O-(2,4,6-三硝基苯基)腺苷5'-三磷酸(TNP-ATP)之间的竞争ATP作为放射性配体。我们的数据表明,苏拉明不能与ATP竞争配体结合位点,而TNP-ATP是竞争性拮抗剂,从而证实了先前的研究[C.A.特鲁希略Nery,A.H。Martins,P。Majumder,F.A。Gonzalez,H。Ulrich,生物化学45(2006)224-233]。此外,我们证明了该测定法可用于结合P2X2受体的RNA适体的体外选择程序。结果表明,该受体可以以稳定的形式固定并在延长的时间段内重复使用,从而促进了配体-受体相互作用的探索以及对可能的配体的组合池的筛选。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号